InduPro raises $77.0M Series B (United States, Aug 2026)

Seattle biotech InduPro raises $77 million to advance cancer treatment pipeline - The Business Journals

InduPro is a biotechnology company focused on defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases. The company is advancing its lead oncology program, IDP-001, which is currently in a Phase 1 clinical study targeting advanced squamous non-small cell lung cancer and other solid tumors. This funding round will support the clinical development and proof-of-concept data generation for IDP-001.

Seattle biotech InduPro raises $77 million to advance cancer treatment pipeline  The Business Journals